Try our Advanced Search for more refined results
Life Sciences - June, 2025
31 articles
- Calif. Suffers Setback In Tariff Suit, But Gets Shot At 9th Circ.
- Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes
- Pharma Group Can Pursue Challenge To Insulin Pricing Law
- Patent Deals Accelerate Access To Generics, Drug Group Says
- Regeneron Gets $407M After Antitrust Win Over Amgen
- 6th Circ. Denies PBMs' Privilege Claim In Opioid MDL
- Canada Customers Agree To Halt 23andMe Data Breach Suits
- Rosen, Pomerantz To Lead Seattle Biotech Class Action
- Latham Advises Atai In $390M Merger With Beckley Psytech
- Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row
- Rocket Startup Launches $400M Deal With Wilbur Ross' SPAC
- Chinese Postdoc Accused Of Smuggling Crop-Blight Fungus
- The Law360 400: A Look At The Top 100 Firms
- Compliance Essentials To Mitigate AI Crime Enforcement Risk
- Adapting To Private Practice: From US Attorney To BigLaw
- Katten Adds 4 Ex-Kirkland Attys To Healthcare Practice
- Crowell & Moring Opens In Boston With Faber Daeufer Tie-Up
- J&J Unit May Owe Around $125M Over AI Tissue Imaging Deal
- Fed. Circ. Skeptical Applicant-Admitted Art Requires Expert
- 23andMe Founder Pushes Alternative Ch. 11 Sale
- Judge Allows Obviousness Defense At Bladder Drug Retrial
- Monthly Merger Review Snapshot
- 4 Mass. Rulings You May Have Missed In May
- Judge Denies UTC Bid To Block Liquidia's Lung Drug
- Most-Favored Nation Drug Pricing Could Shake Up US Pharma
- Allergan Entities Get Booted From Botox Patent Suit In Del.
- Foley & Lardner Opens In Nashville With 3 Holland & Knight Attys
- J&J Again Seeks To Block Beasley Allen In NJ Talc Litigation
- The Ins And Outs Of Consensual Judicial References
- Defamation Litigation Roundup: Cheetos, NASCAR, OpenAI
- High Court Rejects Bard Patent Misuse Dispute